Sofiatan, the stock is in its trading range. If you screen it for 6 months you will see that range is .18-.21. That is what it is. The news that was posted was good but I am not sure it is for a use patent. There has to be phase 1 - 3 human studies and approval from the FDA along the way. That can take years. In the case of CTIC for instance over a decade. The stock is range bound and there is some accumulation going on. What ADMD needs to do is focus hard on their isotope sales. That is their bread and butter and the only place that they are going to create revenue in the long term until the gel can get going. This can have two impacts. Immediate revenue and building a trusting long term clientelle to hopefully be immediate users of the Gel.
Anyone who is saying this is a $.30 or $1 stock is just pumping. Sure there is luck and then there is reality. The revenues and its expansion supports none of that today. That is talking about luck...a $1.